Zobrazeno 1 - 10
of 678
pro vyhledávání: '"K, Kragballe"'
Autor:
Jeanette Henningsen, Claus Johansen, Lars Iversen, Karsten Kristiansen, K. Kragballe, Majken Westergaard
Publikováno v:
Aarhus University
Johansen, C, Kragballe, K, Westergaard, M, Henningsen, J, Kristiansen, K & Iversen, L 2005, ' The mitogen-activated protein kinases p38 and ERK 1/2 are increased in lesional psoriatic skin ', Br. J. Dermatol., vol. 152, no. 1, pp. 37-42 .
Johansen, C, Kragballe, K, Westergaard, M, Henningsen, J, Kristiansen, K & Iversen, L 2005, ' The mitogen-activated protein kinases p38 and ERK 1/2 are increased in lesional psoriatic skin ', Br. J. Dermatol., vol. 152, no. 1, pp. 37-42 .
Summary Background Alterations in specific signal transduction pathways may explain the hyperproliferation and abnormal differentiation of the keratinocytes as well as the increased expression of inflammatory cytokines seen in psoriasis. Major signal
Autor:
Alessandra Comessatti, Henedina Antunes, Maria Hedberg, Atsuko Kitagawa, J. Toole, Etsuko Tadaka, Lennart Emtestam, Akiko Yagami, K. Hoffmann, Giuliana Crisman, Hiromi Sanada, T. Simonart, Gojiro Nakagami, Andrew Yule Finlay, J. Stokkermans-Dubois, Mark Anliker, Teoman Zafer Apan, M.M. Delaunay, Iris Zalaudek, Å. Svensson, A. Bibby, Dolores Wolfram, Maria Teresa Fierro, Gerardo Ferrara, Dagmar Simon, G. Wozel, Florence Dalgard, Takeo Maekawa, Nicole Gilgen Bobalj, Christoph A. Meier, Brunello Wüthrich, Sébastien Thalmann, H. Heikkilä, Lasse R. Braathen, M. Monika Weber, Andreas Blum, Simona Osella Abate, Shin Koie, A. Taieb, Ayşen Karaduman, Alice Wiesner, Marcus Schmitt-Egenolf, Sedat Kaygusuz, Peter Schmid-Grendelmeier, J. Peyri Rey, M. de la Brassinne, Pietro Quaglino, J. Austad, F.G. Bechara, Michela Ortoncelli, C. Fleming, K. Kragballe, Yoshizo Asano, Teresa M. Pereira, Hildegunde Piza-Katzer, Shah Jalal, Martin H. Schöni, M. Sand, Alexandar Tzankov, Kayoko Matsunaga, José Carlos Fernandes, Dirk Schneider, Takashi Nagase, Mauro Novelli, Francesco Cusano, Ana Paula Vieira, Jan Lapins, Nark-Kyoung Rho, F. Cambazard, Karin Sartorius, Giovanni Sarracco, Tetsuo Shiohara, Gonca Boztepe, Jann Lübbe, Z. Williams, S. Tas, Renata Ponti, A. Sousa Basto, Giuseppe Argenziano, Chizuko Konya, Maria Grazia Bernengo, B. Vergier, Emmanuel Laffitte, Tetsushi Yoshikawa, T. Jouary, L. Barnes, Gulsen Akoglu
Publikováno v:
Dermatology. 213:365-367
Publikováno v:
The British journal of dermatology. 168(2)
The European Consensus Programme (ECP) established pan-European consensus definitions of psoriasis disease severity and treatment goals among 19 psoriasis experts from European nations.To use the ECP treatment goals to retrospectively assess adalimum
Publikováno v:
Journal of the European Academy of Dermatology and Venereology : JEADV. 25(10)
Corticosteroids are the mainstay of topical therapies for the treatment of mild to moderate psoriasis. Selection of vehicle, concentrations of corticosteroid and coadministered medications, and frequency of administration are critical factors that en
Publikováno v:
Journal of the European Academy of Dermatology and Venereology : JEADV. 25
Targeted treatment, early intervention and the use of treatment goals is a new approach in medicine that has been implemented across several disciplines (e.g. diabetes, pulmonary arterial hypertension and rheumatoid arthritis) over the last 5-10 year
Publikováno v:
The British journal of dermatology. 164(5)
Adherence to treatment is an indicator of treatment success. Long-term data on adherence to biologic treatment in psoriasis are lacking.To compare the tumour necrosis factor (TNF)-α inhibitors regarding drug survival rate and safety in patients with
Autor:
K Kragballe
Publikováno v:
Journal of Investigative Dermatology. 100(2):205-221
Autor:
C, Johansen, H, Vinter, L, Soegaard-Madsen, L R, Olsen, T, Steiniche, L, Iversen, K, Kragballe
Publikováno v:
The British journal of dermatology. 163(6)
Anti-TNFα therapies are well established for severe psoriasis; however, their mechanism of action in disease resolution is not fully understood. p38 mitogen-activated protein kinase (MAPK) is a kinase known to play a key role in the pathogenesis of
Publikováno v:
The British journal of dermatology. 162(6)
The pathogenesis of psoriasis and the mechanisms of action of antitumour necrosis factor (TNF)-α therapies are incompletely understood.To investigate the early molecular effects of adalimumab in psoriatic skin.Biopsies taken from patients with psori